Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -36,00 | 15,95k | Automatic Disposition | 439,80 - 446,04 | 1,52k | -2,31% |
| 2026-05-18 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -54,00 | 23,46k | Automatic Disposition | 422,47 - 440,70 | 1,56k | -3,35% |
| 2026-05-11 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -400,00 | 178,78k | Automatic Disposition | 446,95 | 6,12k | -6,13% |
| 2026-04-30 | Dr. Monica P. ReedIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,88k | 22,64% |
| 2026-04-30 | Ms. Jami K. Dover NachtsheimIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,90k | 8,33% |
| 2026-04-30 | Mr. Keith R. LeonardIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 901,00 | 143,51% |
| 2026-04-30 | Dr. Amy L. LaddIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 651,00 | 442,50% |
| 2026-04-30 | Ms. Sreelakshmi KolliIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,51k | 54,24% |
| 2026-04-30 | Ms. Amal M. JohnsonInitié | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,55k | 4,08% |
| 2026-04-30 | Mr. Lewis ChewIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,31k | 67,82% |
| 2026-04-30 | Mr. Joseph C. BeeryIndependent Director | 531,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,64k | 17,07% |
| 2026-04-30 | Dr. Craig H. BarrattLead Independent Director | 750,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,95k | 2,76% |
| 2026-04-28 | Dr. Amy L. LaddIndependent Director | -619,00 | 291,89k | Automatic Disposition | 463,50 - 473,46 | 120,00 | -83,76% |
| 2026-03-10 | Dr. Myriam J. Curet McAdamsInitié | -105,00 | 27,78k | Derivative Exercise and Sale | 229,39 - 493,95 | 409,00 | - |
| 2026-03-06 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -1,29k | 630,47k | Automatic Disposition | 485,01 - 490,19 | 1,61k | -44,49% |
| 2026-03-03 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -3,66k | 1,82M | Automatic Disposition | 488,10 - 498,68 | 2,91k | -55,73% |
| 2026-02-28 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 117,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,03k | 12,87% |
| 2026-02-28 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -351,00 | 174,81k | Derivative Exercise and Sale | 487,18 - 503,51 | 1,03k | - |
| 2026-02-27 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -249,00 | 124,43k | Automatic Disposition | 499,71 | 1,03k | -19,53% |
| 2026-03-02 | Dr. Myriam J. Curet McAdamsInitié | -125,00 | 35,46k | Derivative Exercise and Sale | 208,90 - 492,59 | 409,00 | - |
| 2026-03-03 | Dr. Myriam J. Curet McAdamsInitié | -4,73k | 2,30M | Automatic Disposition | 487,18 | 409,00 | -92,04% |
| 2026-02-28 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 4,54k | 0,00 | Derivative Exercise and Retained Stock | - | 33,11k | 15,88% |
| 2026-02-28 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -4,47k | 2,25M | Derivative Exercise and Sale | 503,51 | 33,11k | - |
| 2026-02-28 | Dr. Gary S. GuthartExecutive Chair | 14,54k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 1,14% |
| 2026-02-28 | Dr. Gary S. GuthartExecutive Chair | -14,30k | 7,20M | Derivative Exercise and Sale | 503,51 | 1,29M | - |
| 2026-02-28 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 5,81k | 0,00 | Derivative Exercise and Retained Stock | - | 15,37k | 60,78% |
| 2026-02-28 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -5,72k | 2,88M | Derivative Exercise and Sale | 503,51 | 15,37k | - |
| 2026-02-28 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,59k | 0,00 | Derivative Exercise and Retained Stock | - | 6,52k | 32,14% |
| 2026-02-28 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,56k | 786,48k | Derivative Exercise and Sale | 503,51 | 6,52k | - |
| 2026-02-28 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 6,39k | 0,00 | Derivative Exercise and Retained Stock | - | 11,61k | 122,41% |
| 2026-02-28 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -5,14k | 2,59M | Derivative Exercise and Sale | 503,51 | 11,61k | - |
| 2026-02-28 | Mr. David J. RosaCEO & Director | 12,56k | 0,00 | Derivative Exercise and Retained Stock | - | 245,21k | 5,40% |
| 2026-02-28 | Mr. David J. RosaCEO & Director | -12,36k | 6,22M | Derivative Exercise and Sale | 503,51 | 245,21k | - |
| 2026-02-28 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 4,67k | 0,00 | Derivative Exercise and Retained Stock | - | 6,56k | 245,66% |
| 2026-02-28 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -4,59k | 2,31M | Derivative Exercise and Sale | 503,51 | 6,56k | - |
| 2026-02-28 | Dr. Myriam J. Curet McAdamsInitié | 4,73k | 0,00 | Derivative Exercise and Retained Stock | - | 5,14k | 1 155,99% |
| 2026-02-28 | Dr. Myriam J. Curet McAdamsInitié | -4,65k | 2,34M | Derivative Exercise and Sale | 503,51 | 5,14k | - |
| 2026-02-27 | Dr. Myriam J. Curet McAdamsInitié | -2,35k | 1,17M | Automatic Disposition | 499,71 | 5,14k | -31,34% |
| 2026-02-26 | Ms. Patricia L. WadorsSenior VP & Chief HR Officer | -458,00 | 230,40k | Derivative Exercise and Sale | 499,71 - 506,17 | 0,00 | - |
| 2026-02-26 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 1,34k | 0,00 | Derivative Exercise and Retained Stock | - | 28,57k | 4,91% |
| 2026-02-26 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -972,00 | 492,00k | Derivative Exercise and Sale | 506,17 | 28,57k | - |
| 2026-02-26 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 1,52k | 0,00 | Derivative Exercise and Retained Stock | - | 5,22k | 41,20% |
| 2026-02-26 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -1,22k | 619,55k | Derivative Exercise and Sale | 506,17 | 5,22k | - |
| 2026-02-26 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 1,76k | 0,00 | Derivative Exercise and Retained Stock | - | 9,56k | 22,54% |
| 2026-02-26 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -1,64k | 829,11k | Derivative Exercise and Sale | 506,17 | 9,56k | - |
| 2026-02-26 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,23k | 0,00 | Derivative Exercise and Retained Stock | - | 4,93k | 33,21% |
| 2026-02-26 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,21k | 613,48k | Derivative Exercise and Sale | 506,17 | 4,93k | - |
| 2026-02-26 | Dr. Myriam J. Curet McAdamsInitié | 2,35k | 0,00 | Derivative Exercise and Retained Stock | - | 2,75k | 573,35% |
| 2026-02-26 | Dr. Myriam J. Curet McAdamsInitié | -2,31k | 1,17M | Derivative Exercise and Sale | 506,17 | 2,75k | - |
| 2026-02-26 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 498,00 | 0,00 | Derivative Exercise and Retained Stock | - | 1,16k | 75,45% |
| 2026-02-26 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -491,00 | 248,53k | Derivative Exercise and Sale | 506,17 | 1,16k | - |
| 2026-02-26 | Mr. David J. RosaCEO & Director | 3,08k | 0,00 | Derivative Exercise and Retained Stock | - | 232,65k | 1,34% |
| 2026-02-26 | Mr. David J. RosaCEO & Director | -3,03k | 1,53M | Derivative Exercise and Sale | 506,17 | 232,65k | - |
| 2026-02-26 | Dr. Gary S. GuthartExecutive Chair | 4,23k | 0,00 | Derivative Exercise and Retained Stock | - | 1,27M | 0,33% |
| 2026-02-26 | Dr. Gary S. GuthartExecutive Chair | -4,16k | 2,11M | Derivative Exercise and Sale | 506,17 | 1,27M | - |
| 2026-02-26 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 1,31k | 0,00 | Derivative Exercise and Retained Stock | - | 1,90k | 220,78% |
| 2026-02-26 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -1,29k | 651,95k | Derivative Exercise and Sale | 506,17 | 1,90k | - |
| 2026-02-10 | Dr. Myriam J. Curet McAdamsInitié | -943,00 | 441,74k | Derivative Exercise and Sale | 229,39 - 494,96 | 409,00 | - |
| 2026-02-10 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | 132,00 | 0,00 | Derivative Exercise and Retained Stock | - | 660,00 | 25,00% |
| 2026-02-10 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -435,00 | 214,67k | Derivative Exercise and Sale | 492,84 - 494,96 | 660,00 | - |
| 2026-02-10 | Mr. David J. RosaCEO & Director | 712,00 | 0,00 | Derivative Exercise and Retained Stock | - | 229,57k | 0,31% |
| 2026-02-10 | Mr. David J. RosaCEO & Director | -724,00 | 356,82k | Derivative Exercise and Sale | 492,84 | 229,57k | - |
| 2026-02-10 | Dr. Gary S. GuthartExecutive Chair | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 1,27M | 0,10% |
| 2026-02-10 | Dr. Gary S. GuthartExecutive Chair | -1,31k | 643,65k | Derivative Exercise and Sale | 492,84 | 1,27M | - |
| 2026-02-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 143,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 4,02% |
| 2026-02-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -172,00 | 84,77k | Derivative Exercise and Sale | 492,84 | 3,70k | - |
| 2026-02-10 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | 529,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,23k | 1,98% |
| 2026-02-10 | Dr. Iman JeddiSenior VP & GM of da Vinci Platforms & Product Operations | -309,00 | 152,29k | Derivative Exercise and Sale | 492,84 | 27,23k | - |
| 2026-02-10 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | 581,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,80k | 8,05% |
| 2026-02-10 | Mr. Jamie E. SamathExec. VP, CFO & Enterprise Technology Leader | -496,00 | 244,45k | Derivative Exercise and Sale | 492,84 | 7,80k | - |
| 2026-02-10 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | 585,00 | 0,00 | Derivative Exercise and Retained Stock | - | 3,70k | 18,80% |
| 2026-02-10 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -492,00 | 242,48k | Derivative Exercise and Sale | 492,84 | 3,70k | - |
| 2026-02-10 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | 405,00 | 0,00 | Derivative Exercise and Retained Stock | - | 592,00 | 216,58% |
| 2026-02-10 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -433,00 | 213,40k | Derivative Exercise and Sale | 492,84 | 592,00 | - |
| 2026-01-29 | Mr. Keith R. LeonardIndependent Director | -369,00 | 0,00 | Other Disposition | - | 370,00 | -49,93% |
| 2026-01-29 | Dr. Myriam J. Curet McAdamsInitié | -126,00 | 39,20k | Derivative Exercise and Sale | 208,90 - 520,02 | 353,00 | - |
| 2026-01-27 | Dr. Myriam J. Curet McAdamsInitié | -230,00 | 72,30k | Derivative Exercise and Sale | 208,90 - 532,61 | 353,00 | - |
| 2026-01-27 | Dr. Gary S. GuthartExecutive Chair | -25,50k | 9,08M | Derivative Exercise and Sale | 174,26 - 531,53 | 1,27M | - |
| 2026-01-27 | Dr. Gary S. GuthartExecutive Chair | -1,80k | 956,74k | Automatic Disposition | 531,52 - 531,53 | 1,27M | -0,14% |
| 2025-12-15 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -464,00 | 254,50k | Automatic Disposition | 548,49 | 131,00 | -77,98% |
| 2025-12-12 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -312,00 | 170,78k | Automatic Disposition | 547,36 | 595,00 | -34,40% |
| 2025-12-12 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -4,50k | 2,10M | Derivative Exercise and Sale | 79,64 - 547,36 | 595,00 | - |
| 2025-12-10 | Dr. Myriam J. Curet McAdamsInitié | -104,00 | 34,37k | Derivative Exercise and Sale | 229,39 - 559,90 | 353,00 | - |
| 2025-12-01 | Dr. Myriam J. Curet McAdamsInitié | -125,00 | 45,01k | Derivative Exercise and Sale | 208,90 - 568,99 | 353,00 | - |
| 2025-12-01 | Dr. Gary S. GuthartExecutive Chair | 2,69k | 375,87k | Derivative Exercise and Retained Stock | 139,52 | 1,27M | 0,21% |
| 2025-12-01 | Dr. Gary S. GuthartExecutive Chair | -22,81k | 9,84M | Derivative Exercise and Sale | 139,52 - 570,89 | 1,27M | - |
| 2025-11-12 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -9,00k | 3,15M | Derivative Exercise and Sale | 177,99 - 580,00 | 3,06k | - |
| 2025-11-12 | Mr. Henry L. CharltonExec. VP and Chief Commercial & Marketing Officer | -4,73k | 2,74M | Automatic Disposition | 580,00 | 3,06k | -60,76% |
| 2025-11-12 | Dr. Craig H. BarrattLead Independent Director | -750,00 | 381,51k | Derivative Exercise and Sale | 71,32 - 580,00 | 27,20k | - |
| 2025-11-12 | Mr. Keith R. LeonardIndependent Director | -1,61k | 0,00 | Other Disposition | - | 739,00 | -68,49% |
| 2025-11-10 | Dr. Myriam J. Curet McAdamsInitié | -105,00 | 34,71k | Derivative Exercise and Sale | 229,39 - 560,00 | 353,00 | - |
| 2025-11-10 | Dr. Brian E. MillerInitié | -3,50k | 1,25M | Derivative Exercise and Sale | 208,90 - 575,00 | 5,76k | - |
| 2025-11-05 | Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller | -2,07k | 980,48k | Derivative Exercise and Sale | 59,46 - 550,00 | 473,00 | - |
| 2025-11-03 | Mr. David J. RosaCEO & Director | -5,45k | 0,00 | Other Disposition | - | 228,80k | -2,33% |
| 2025-10-28 | Dr. Myriam J. Curet McAdamsInitié | -7,69k | 2,42M | Derivative Exercise and Sale | 208,90 - 548,43 | 353,00 | - |
| 2025-10-24 | Dr. Gary S. GuthartExecutive Chair | 4,40k | 481,74k | Derivative Exercise and Retained Stock | 109,49 | 1,27M | 0,35% |
| 2025-10-24 | Dr. Gary S. GuthartExecutive Chair | -31,60k | 13,84M | Derivative Exercise and Sale | 109,49 - 547,56 | 1,27M | - |
| 2025-10-24 | Dr. Craig H. BarrattLead Independent Director | -2,19k | 1,05M | Derivative Exercise and Sale | 71,32 - 548,01 | 27,20k | - |
| 2025-10-24 | Mr. David J. RosaCEO & Director | 2,50k | 199,09k | Derivative Exercise and Retained Stock | 79,64 | 234,26k | 1,08% |
| 2025-10-24 | Mr. David J. RosaCEO & Director | -24,50k | 11,46M | Derivative Exercise and Sale | 79,64 - 547,55 | 234,26k | - |
| 2025-10-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | 1,32k | 0,00 | Derivative Exercise and Retained Stock | - | 3,56k | 58,62% |
| 2025-10-10 | Mr. Gary H. LoebExec. VP and Chief Legal & Compliance Officer | -1,30k | 575,11k | Derivative Exercise and Sale | 443,76 | 3,56k | - |
| 2025-09-03 | Dr. Amy L. LaddIndependent Director | -671,00 | 305,59k | Automatic Disposition | 440,69 - 470,11 | 739,00 | -47,59% |
| 2025-08-29 | Dr. Gary S. GuthartExecutive Chair | 6,64k | 528,79k | Derivative Exercise and Retained Stock | 79,64 | 1,26M | 0,53% |
| 2025-08-29 | Dr. Gary S. GuthartExecutive Chair | -29,36k | 11,53M | Derivative Exercise and Sale | 79,64 - 472,49 | 1,26M | - |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -7,89k | 3,47M | Derivative Exercise and Sale | 59,46 - 498,64 | 1,26M | - |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -2,80k | 1,39M | Automatic Disposition | 495,23 - 495,24 | 1,26M | -0,22% |
| 2025-07-28 | Dr. Gary S. GuthartExecutive Chair | -10,50k | 0,00 | Other Disposition | - | 1,26M | -0,83% |
| 2025-07-25 | Dr. Myriam J. Curet McAdamsInitié | -4,50k | 1,13M | Derivative Exercise and Sale | 242,34 - 492,48 | 353,00 | - |
| 2025-06-10 | Mr. David J. RosaCEO & Director | 684,00 | 0,00 | Derivative Exercise and Retained Stock | - | 231,76k | 0,30% |
| 2025-06-10 | Mr. David J. RosaCEO & Director | -674,00 | 354,63k | Derivative Exercise and Sale | 526,15 | 231,76k | - |
| 2025-06-05 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -431,00 | 242,18k | Automatic Disposition | 560,70 - 563,11 | 907,00 | -32,21% |
| 2025-06-04 | Mr. David J. RosaCEO & Director | -851,00 | 0,00 | Other Disposition | - | 231,07k | -0,37% |
| 2025-06-02 | Mr. Mark P. BrosiusExec. VP and Chief Manufacturing & Supply Chain Officer | -645,00 | 355,14k | Automatic Disposition | 549,06 - 552,07 | 1,34k | -32,53% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
